Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for ICU.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 4.296M
March 31, 2026 7.315M
December 31, 2025 10.42M
September 30, 2025 11.46M
June 30, 2025 3.341M
March 31, 2025 0.565M
December 31, 2024 -2.183M
September 30, 2024 -2.052M
June 30, 2024 -6.901M
March 31, 2024 -4.473M
December 31, 2023 -13.87M
September 30, 2023 -15.90M
Date Value
June 30, 2023 -11.45M
March 31, 2023 -10.88M
December 31, 2022 -20.76M
September 30, 2022 97.95M
June 30, 2022 98.57M
March 31, 2022 98.39M
December 31, 2021 -2.816M
September 30, 2021 94.89M
June 30, 2021 94.65M
March 31, 2021 96.64M
December 31, 2020 0.0198M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 51.11B
AngioDynamics, Inc. 170.82M
Alphatec Holdings, Inc. 11.53M
AtriCure, Inc. 516.43M
Baxter International, Inc. 6.206B

Shareholders Equity (Quarterly) Related Metrics